Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells

Chinese Medical Journal

Volumn 116, Issue 2, 2003, Pages 203-207

  Xiao, Enhua ^a   Li, Detai ^a   Shen, Shubin ^a   Zhou, Shunke ^a   Tan, Lihua ^a   Wang, Yunhua ^a   Luo, Jianguang ^a   Wu, Yuzhi ^a   Tan, Changlian ^a   Liu, Hui ^a   Zhu, Hui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; GELATIN SPONGE; IODINATED POPPYSEED OIL; PROTEIN BAX; PROTEIN BCL 2; TRANSFERASE;

ADULT; AGED; APOPTOSIS; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CARCINOMA CELL; CELL LEVEL; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0037322587     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ueno K, Miyazono N, Inoue H, et al. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000;88: 1574-1581.
2. Kerr J, Winterford C, Harmon B. Apoptosis: its significance in cancer and cancer therapy. Cancer 1993;73:2013-2026.
3. Oltvai ZN. Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
4. Rose DM, Chapman WC, Brockenbrough AT, et al. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999;177: 405-410.
5. Wijsman JH, Jonker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
6. Reed JC. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 1995;9:451-473.
7. Yang LJ, Si XH, Wang WL. Overexpression of bcl-2 protects hepatoma cell line HCC-9204 from ethanol-induced apoptosis. Chin Med J 2002;115:8-11.
8. Zhan Q, Bieczczad CK, Bae I, et al. Induction of bcl-2 family member Mcl1 as an early reponse to DNA damage. Oncogene 1997;14:1031-1039.
9. Sakakura C, Sweeney EA, Shirahama T, et al. Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 1996;67:101-105.
10. Liu YJ, Mason DY, Johnson GD, et al. Germinal center cells express bcl-2 protein after activation by signals, which prevent their entry into apoptosis. Eur J Immunol 1991;21:1905-1910.
11. Park IC, Park MJ, Hwang CS, et al. Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. Cancer Letters 2000;158:125-132.
12. Castaneda F, Kinne RK. Effects of doxorubicin, mitomycin C and ethanol on Hep-G2 cells in vitro. J Cancer Res Clin Oncol 1999;125:1-8.
13. An WG, Kanekal M, Simon MC, et al. Stabilization of wild-type p53 by hypoxia-inducile factor 1α. Nature 1998;392:405-408.
14. Seraldi G, Shaklec Cl, Simon B, et al. Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology 1998;27: 1584-1591.
15. Hsu HC, Sheu JC, Lin YH, et al. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan: a comparison with resected large HCC. Cancer 1985;56:672.
16. Kenji I. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991;68:2150-2154.
17. Spreafico C, Marchiano A, Regalia E, et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994;192:687-690.
18. Zhang ZJ, Wu MC, Liu Q, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Chin J Oncol 1999;21:214-216.